BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9224565)

  • 21. Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway.
    Rincón M; Enslen H; Raingeaud J; Recht M; Zapton T; Su MS; Penix LA; Davis RJ; Flavell RA
    EMBO J; 1998 May; 17(10):2817-29. PubMed ID: 9582275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p38 MAP kinase regulates TNF alpha-, IL-1 alpha- and PAF-induced RANTES and GM-CSF production by human bronchial epithelial cells.
    Hashimoto S; Matsumoto K; Gon Y; Maruoka S; Kujime K; Hayashi S; Takeshita I; Horie T
    Clin Exp Allergy; 2000 Jan; 30(1):48-55. PubMed ID: 10606930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumour necrosis factor-alpha-induced phosphorylation and activation of cytosolic phospholipase A2 are abrogated by an inhibitor of the p38 mitogen-activated protein kinase cascade in human neutrophils.
    Waterman WH; Molski TF; Huang CK; Adams JL; Sha'afi RI
    Biochem J; 1996 Oct; 319 ( Pt 1)(Pt 1):17-20. PubMed ID: 8870643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct roles for p42/p44 and p38 mitogen-activated protein kinases in the induction of IL-2 by IL-1.
    Matthews JS; O'Neill LA
    Cytokine; 1999 Sep; 11(9):643-55. PubMed ID: 10479400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel substituted pyridinyl imidazoles as potent anticytokine agents with low activity against hepatic cytochrome P450 enzymes.
    Laufer SA; Wagner GK; Kotschenreuther DA; Albrecht W
    J Med Chem; 2003 Jul; 46(15):3230-44. PubMed ID: 12852754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thioredoxin negatively regulates p38 MAP kinase activation and IL-6 production by tumor necrosis factor-alpha.
    Hashimoto S; Matsumoto K; Gon Y; Furuichi S; Maruoka S; Takeshita I; Hirota K; Yodoi J; Horie T
    Biochem Biophys Res Commun; 1999 May; 258(2):443-7. PubMed ID: 10329406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Raf-1 is activated by the p38 mitogen-activated protein kinase inhibitor, SB203580.
    Kalmes A; Deou J; Clowes AW; Daum G
    FEBS Lett; 1999 Feb; 444(1):71-4. PubMed ID: 10037150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-alpha or FMLP stimulation.
    Zu YL; Qi J; Gilchrist A; Fernandez GA; Vazquez-Abad D; Kreutzer DL; Huang CK; Sha'afi RI
    J Immunol; 1998 Feb; 160(4):1982-9. PubMed ID: 9469462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p38 Mitogen-activated protein kinase regulates IL-8 expression in human pulmonary vascular endothelial cells.
    Hashimoto S; Matsumoto K; Gon Y; Maruoka S; Takeshita I; Hayashi S; Koura T; Kujime K; Horie T
    Eur Respir J; 1999 Jun; 13(6):1357-64. PubMed ID: 10445612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5-b]pyridin-2-one-Based p38 MAP Kinase Inhibitors: Part 1.
    Kaieda A; Takahashi M; Fukuda H; Okamoto R; Morimoto S; Gotoh M; Miyazaki T; Hori Y; Unno S; Kawamoto T; Tanaka T; Itono S; Takagi T; Sugimoto H; Okada K; Snell G; Bertsch R; Nguyen J; Sang BC; Miwatashi S
    ChemMedChem; 2019 May; 14(10):1022-1030. PubMed ID: 30945818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calmodulin-dependent activation of p38 and p42/44 mitogen-activated protein kinases contributes to c-fos expression by calcium in PC12 cells: modulation by nitric oxide.
    Lee SA; Park JK; Kang EK; Bae HR; Bae KW; Park HT
    Brain Res Mol Brain Res; 2000 Jan; 75(1):16-24. PubMed ID: 10648884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates.
    Fukunaga R; Hunter T
    EMBO J; 1997 Apr; 16(8):1921-33. PubMed ID: 9155018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetic mechanism of the p38-alpha MAP kinase: phosphoryl transfer to synthetic peptides.
    Chen G; Porter MD; Bristol JR; Fitzgibbon MJ; Pazhanisamy S
    Biochemistry; 2000 Feb; 39(8):2079-87. PubMed ID: 10684658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelin-1 activates p38 mitogen-activated protein kinase and cytosolic phospholipase A2 in cat iris sphincter smooth muscle cells.
    Husain S; Abdel-Latif AA
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):87-96. PubMed ID: 10432304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperosmolarity-induced interleukin-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein kinase.
    Hashimoto S; Matsumoto K; Gon Y; Nakayama T; Takeshita I; Horie T
    Am J Respir Crit Care Med; 1999 Feb; 159(2):634-40. PubMed ID: 9927384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of p38 mitogen-activated protein kinase in heat shock protein 27 induction in human neutrophils.
    Niwa M; Hotta K; Kanamori Y; Hatakeyama D; Hirade K; Katayama M; Hara A; Mori H; Ito H; Kato K; Matsuno H; Uematsu T; Kozawa O
    Eur J Pharmacol; 2003 Apr; 466(3):245-53. PubMed ID: 12694807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion.
    Simon C; Goepfert H; Boyd D
    Cancer Res; 1998 Mar; 58(6):1135-9. PubMed ID: 9515796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of arachidonate release and cytosolic phospholipase A2 via extracellular signal-regulated kinase and p38 mitogen-activated protein kinase in macrophages stimulated by bacteria or zymosan.
    Hiller G; Sundler R
    Cell Signal; 1999 Dec; 11(12):863-9. PubMed ID: 10659994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5-b]Pyridin-2-one-Based p38 MAP Kinase Inhibitors: Part 2.
    Kaieda A; Takahashi M; Fukuda H; Okamoto R; Morimoto S; Gotoh M; Miyazaki T; Hori Y; Unno S; Kawamoto T; Tanaka T; Itono S; Takagi T; Sugimoto H; Okada K; Lane W; Sang BC; Saikatendu K; Matsunaga S; Miwatashi S
    ChemMedChem; 2019 Dec; 14(24):2093-2101. PubMed ID: 31697454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-interactions of two p38 mitogen-activated protein (MAP) kinase inhibitors and two cholecystokinin (CCK) receptor antagonists with the CCK1 receptor and p38 MAP kinase.
    Morel C; Ibarz G; Oiry C; Carnazzi E; Bergé G; Gagne D; Galleyrand JC; Martinez J
    J Biol Chem; 2005 Jun; 280(22):21384-93. PubMed ID: 15772081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.